Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders—A Systematic Review and Meta-Analysis
- 16 October 2024
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (1) , 135-150
Abstract
INTRODUCTION: Pouchitis and Crohn's-like disease of the pouch (CLDP) are common in patients who undergo ileal pouch anal anastomosis for ulcerative colitis. We conducted separate systematic reviews to evaluate the effectiveness of available interventions to prevent and treat pouchitis and CLDP. METHODS: Through systematic literature reviews, we identified studies that evaluated the effectiveness of probiotics, antibiotics, 5-aminosalicylates, nonsystemic oral corticosteroids, and advanced therapies for prevention and treatment of pouchitis and CLDP for meta-analysis. Primary outcomes were occurrence of pouchitis for pouchitis prevention and clinical response for pouchitis and CLDP treatment. We estimated the relative effectiveness of these interventions using the existing placebo response rates or hypothetical spontaneous improvement rates derived from clinical trials of pouchitis, ulcerative colitis, and Crohn's disease. RESULTS: Probiotics were effective for primary (relative risk [RR] 0.18; 95% confidence interval [CI] 0.05–0.62) and secondary prevention (RR 0.17; 95% CI 0.09–0.34) of pouchitis. Antibiotics were effective for treatment of acute and chronic pouchitis (12 cohorts; RR 1.67; 95% CI 1.34–2.01; response rate 65%; 95% CI 52–75) with ciprofloxacin and metronidazole-based regimens being more effective than rifaximin. Advanced therapies were effective for treatment of chronic antibiotic-refractory pouchitis (31 cohorts; RR 1.71; 95% CI 1.28–2.56; response rate 50%; 95% CI 43–57) and CLDP (10 cohorts; RR 2.49; 95% CI 1.87–3.73; response rate 74%; 95% CI 68–79) without significant difference between classes. DISCUSSION: Multiple medical interventions are effective for prevention and treatment of pouchitis and CLDP. Given the overall low quality of data, further research is needed to confirm these findings.Keywords
This publication has 78 references indexed in Scilit:
- The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitisSurgery Today, 2015
- Quality of life after proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitisInternational Journal of Colorectal Disease, 2013
- Adalimumab therapy in Crohnʼs disease of the ileal pouchInflammatory Bowel Diseases, 2012
- Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter studyInflammatory Bowel Diseases, 2012
- Infliximab and/or Azathioprine in the Treatment of Crohn's Disease-Like Complications After IPAADiseases of the Colon & Rectum, 2011
- Efficacy of infliximab in refractory pouchitis and Crohnʼs disease-related complications of the pouch: A Belgian case seriesInflammatory Bowel Diseases, 2010
- Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cellsInflammatory Bowel Diseases, 2008
- Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot studyInflammatory Bowel Diseases, 2007
- Prospective Study of the Incidence, Timing, and Treatment of Pouchitis in 104 Consecutive Patients After Restorative ProctocolectomyArchives of Surgery, 1996
- Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitisDigestive Diseases and Sciences, 1994